The New England journal of medicine, 2019-06, Vol.380 (25), p.2395-2405
- Sparano, Joseph A
- Gray, Robert J
- Ravdin, Peter M
- Makower, Della F
- Pritchard, Kathleen I
- Albain, Kathy S
- Hayes, Daniel F
- Geyer, Charles E
- Dees, Elizabeth C
- Goetz, Matthew P
- Olson, John A
- Lively, Tracy
- Badve, Sunil S
- Saphner, Thomas J
- Wagner, Lynne I
- Whelan, Timothy J
- Ellis, Matthew J
- Paik, Soonmyung
- Wood, William C
- Keane, Maccon M
- Gomez Moreno, Henry L
- Reddy, Pavan S
- Goggins, Timothy F
- Mayer, Ingrid A
- Brufsky, Adam M
- Toppmeyer, Deborah L
- Kaklamani, Virginia G
- Berenberg, Jeffrey L
- Abrams, Jeffrey
- Sledge, George W
2019
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Sparano, Joseph A
- Gray, Robert J
- Ravdin, Peter M
- Makower, Della F
- Pritchard, Kathleen I
- Albain, Kathy S
- Hayes, Daniel F
- Geyer, Charles E
- Dees, Elizabeth C
- Goetz, Matthew P
- Olson, John A
- Lively, Tracy
- Badve, Sunil S
- Saphner, Thomas J
- Wagner, Lynne I
- Whelan, Timothy J
- Ellis, Matthew J
- Paik, Soonmyung
- Wood, William C
- Keane, Maccon M
- Gomez Moreno, Henry L
- Reddy, Pavan S
- Goggins, Timothy F
- Mayer, Ingrid A
- Brufsky, Adam M
- Toppmeyer, Deborah L
- Kaklamani, Virginia G
- Berenberg, Jeffrey L
- Abrams, Jeffrey
- Sledge, George W
- Titel
- Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
- Ist Teil von
- The New England journal of medicine, 2019-06, Vol.380 (25), p.2395-2405
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2019
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- TAILORx established the role of the 21-gene predictor of genetic risk in ascertaining treatment for women with hormone-receptor–positive, human epidermal growth factor receptor 2–negative breast cancer. Clinical risk factors provided additional prognostic information for women with intermediate genetic risk.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa1904819Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6709671
- Format
- –
- Schlagworte
- Adjuvant therapy, Adjuvants, Adult, Age, Age Factors, Aged, Algorithms, Antineoplastic Agents, Hormonal - therapeutic use, Breast cancer, Breast Neoplasms - drug therapy, Breast Neoplasms - genetics, Breast Neoplasms - surgery, Cancer therapies, Chemotherapy, Chemotherapy, Adjuvant, Clinical trials, Confidence intervals, Disease-Free Survival, Endocrine therapy, Epidermal growth factor, Estrogen Antagonists - therapeutic use, Female, Gene Expression Profiling, Humans, Medical prognosis, Medical research, Middle Aged, Neoplasm Recurrence, Local - genetics, Neoplasm Recurrence, Local - prevention & control, Oncology, Premenopause, Prognosis, Proportional Hazards Models, Prospective Studies, Receptor, ErbB-2, Risk Factors, Statistical analysis, Tamoxifen, Tamoxifen - therapeutic use, Womens health